This company has been marked as potentially delisted and may not be actively trading. NASDAQ:DRAD Digirad (DRAD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Digirad Stock (NASDAQ:DRAD) 30 days 90 days 365 days Advanced Chart Get Digirad alerts:Sign Up Key Stats Today's Range$2.04▼$2.0450-Day Range$2.79▼$4.6552-Week Range$1.99▼$8.84Volume493 shsAverage Volume485,592 shsMarket Capitalization$9.69 millionP/E RatioN/ADividend Yield108.11%Price TargetN/AConsensus RatingN/A Company OverviewDigirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.Read More… Receive DRAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter. Email Address DRAD Stock News HeadlinesApril 19th Options Now Available For Karuna Therapeutics (KRTX)January 7, 2024 | nasdaq.com2 girls dead, 1 hospitalized after possible overdoses at high schoolMay 20, 2023 | cbsnews.comHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.April 26, 2025 | Brownstone Research (Ad)Connecticut teachers thought 5-year-old boy was just 'playing dead' before he died, lawsuit claimsApril 23, 2023 | usatoday.comLisa Marie Presley dead at 54 after cardiac arrest: ‘My beautiful daughter’January 16, 2023 | nypost.comRock icon Jeff Beck dead at 78January 14, 2023 | foxnews.comGlobal Nuclear Medicine Equipment Market Report to 2030 - Featuring Siemens Healthineers, Fujifilm Holdings, Canon and Digirad Among Others - ResearchAndMarkets.com - Business WireOctober 12, 2022 | businesswire.comGlobal Single Photon Emission Computed Tomography (SPECT) Market to Reach $2.7 Billion by 2027 - Yahoo FinanceOctober 11, 2022 | finance.yahoo.comSee More Headlines DRAD Stock Analysis - Frequently Asked Questions How were Digirad's earnings last quarter? Digirad Co. (NASDAQ:DRAD) issued its quarterly earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.34. The medical equipment provider had revenue of $30.35 million for the quarter. Digirad had a negative trailing twelve-month return on equity of 3.75% and a negative net margin of 5.32%. When did Digirad's stock split? Digirad shares reverse split on Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Digirad own? Based on aggregate information from My MarketBeat watchlists, some other companies that Digirad investors own include AT&T (T), GE Aerospace (GE), Gilead Sciences (GILD), Biocept (BIOC), Exelixis (EXEL), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings11/18/2020Today4/26/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:DRAD CIK707388 Webwww.digirad.com Phone858-726-1600FaxN/AEmployees618Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,630,000.00 Net Margins-5.32% Pretax MarginN/A Return on Equity-3.75% Return on Assets-0.85% Debt Debt-to-Equity Ratio0.88 Current Ratio1.27 Quick Ratio0.91 Sales & Book Value Annual Sales$114.18 million Price / Sales0.08 Cash Flow$2.95 per share Price / Cash Flow0.69 Book Value$10.30 per share Price / Book0.20Miscellaneous Outstanding Shares4,760,000Free FloatN/AMarket Cap$9.69 million OptionableNot Optionable Beta0.18 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:DRAD) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.